Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of18F-DOPA PET/MRI for the Detection and Localization of Focal Forms of Hyperinsulinism

NCT05088798 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

NCT NCT05088798
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05088798 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of18F-DOPA PET/MRI for the Detection and Localization of Focal Forms of Hyperinsulinism
Lead sponsor
Washington University School of Medicine
Phase
Phase 2
Overall status
Recruiting
Start date
September 10, 2020
Completion date
January 1, 2030
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hyperinsulinism